Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neuron23
Research
Blocking enzyme saved mice from known Parkinson’s mechanism
Several companies, like Denali Therapeutics and Neuron23, are targeting the mechanism in phase 2 trials.
Darren Incorvaia
Jul 2, 2025 5:26pm
Leaps by Bayer chief jumps to Bayer, too—Chutes & Ladders
Aug 25, 2023 9:30am
Qiagen to develop companion diagnostic for Parkinson's drug
Sep 16, 2022 11:53am
Pfizer taps former CVS exec Denton for CFO role—Chutes & Ladders
Apr 15, 2022 9:30am
Neuron23 snags $100M, new Parkinson's disease candidate
Mar 30, 2022 5:00am
Neuron23 uncloaks with $113.5M to tackle CNS disorders
Dec 16, 2020 4:45am